CITED2 Gene Atrial Septal Defect Type 8 NGS Genetic DNA Test
Comprehensive Introduction to Cardiac Genetic Testing
The CITED2 Gene Atrial Septal Defect Type 8 NGS Genetic DNA Test represents a breakthrough in cardiovascular genetic diagnostics. This specialized test focuses on identifying mutations in the CITED2 gene, which plays a critical role in heart development during embryonic stages. Atrial septal defects are among the most common congenital heart abnormalities, affecting thousands of newborns annually in the United States. Early detection through genetic testing enables proactive medical management and improved patient outcomes.
What This Advanced Test Detects
Our comprehensive NGS-based analysis specifically targets:
- Pathogenic variants in the CITED2 gene associated with atrial septal defect type 8
- Single nucleotide polymorphisms (SNPs) affecting cardiac development
- Copy number variations impacting heart formation pathways
- Genetic markers linked to congenital heart disease susceptibility
- Inheritance patterns for family genetic counseling
Technical Methodology
Utilizing cutting-edge Next Generation Sequencing technology, our test provides unparalleled accuracy in detecting genetic variations. The process involves comprehensive genomic analysis of the CITED2 gene region, ensuring thorough coverage of all potential mutation sites. This advanced approach significantly enhances detection sensitivity compared to traditional genetic testing methods.
Who Should Consider This Genetic Test
This specialized cardiac genetic test is recommended for individuals experiencing:
- Family history of congenital heart defects or atrial septal abnormalities
- Unexplained cardiac symptoms in infancy or childhood
- Developmental delays associated with potential heart conditions
- Multiple family members with cardiovascular disorders
- Previous inconclusive cardiac diagnostic results
- Planning for pregnancy with family cardiac history
Clinical Indications
Patients presenting with symptoms such as heart murmurs, breathing difficulties, fatigue during feeding (in infants), or poor growth patterns should strongly consider this genetic evaluation. Early identification of CITED2 gene mutations can guide appropriate medical interventions and prevent complications.
Significant Benefits of Genetic Testing
Undergoing the CITED2 Gene Atrial Septal Defect Type 8 test provides numerous advantages:
- Early Intervention Opportunities: Enables proactive medical management before symptoms worsen
- Personalized Treatment Planning: Guides cardiologists in developing targeted treatment strategies
- Family Genetic Counseling: Provides crucial information for family planning decisions
- Improved Prognostic Accuracy: Enhances understanding of disease progression and potential outcomes
- Reduced Diagnostic Uncertainty: Offers definitive answers for complex cardiac presentations
- Cost-Effective Healthcare: Prevents unnecessary medical procedures through accurate diagnosis
Understanding Your Test Results
Our comprehensive genetic counseling team provides detailed interpretation of your results:
Positive Result Guidance
A positive result indicates the presence of CITED2 gene mutations associated with atrial septal defects. This finding enables:
- Immediate consultation with pediatric or adult cardiologists
- Development of specialized monitoring protocols
- Consideration of surgical interventions if indicated
- Family member screening recommendations
Negative Result Interpretation
A negative result suggests the absence of detectable CITED2 mutations, though continued cardiac monitoring may still be recommended based on clinical presentation and family history.
Variant of Uncertain Significance
Some genetic variations require additional research and family studies for proper classification. Our genetic counselors provide ongoing support and updated interpretations as new information becomes available.
Test Pricing and Availability
| Price Type | Amount (USD) |
|---|---|
| Discount Price | $500 |
| Regular Price | $700 |
Testing Process Details
- Turnaround Time: 3 to 4 weeks
- Sample Type: Blood, Extracted DNA, or One drop Blood on FTA Card
- Pre-test Requirements: Complete clinical history and genetic counseling session
- Specialty: Cardiology and Genetics
- Methodology: Next Generation Sequencing (NGS) Technology
Nationwide Testing Availability
We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our network of certified genetic counselors and cardiology specialists ensures comprehensive care regardless of your location.
Take Action for Your Cardiac Health
Don’t wait to address potential genetic cardiac concerns. Our expert team is ready to provide the advanced genetic testing and counseling you need. Schedule your CITED2 Gene Atrial Septal Defect Type 8 NGS Genetic DNA Test today and take the first step toward comprehensive cardiac health management.
Call or WhatsApp us now at +1(267) 388-9828 to book your appointment or request additional information about this vital genetic screening.
Early detection through genetic testing can make a significant difference in managing congenital heart conditions. Trust our experienced team to provide accurate, reliable results and comprehensive genetic counseling support throughout your testing journey.
